HomeLab Tests17-Hydroxyprogesterone
Back to Lab Tests
17-Hydroxyprogesterone
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Lab Tests

17-Hydroxyprogesterone

The 17-hydroxyprogesterone (17-OHP) test measures a hormone produced by the adrenal glands to screen for and diagnose congenital adrenal hyperplasia (CAH).

Overview

17-hydroxyprogesterone (17-OHP) is a substance produced by your adrenal glands, which are small organs located on top of each kidney. Normally, the body uses 17-OHP to produce cortisol, a hormone essential for controlling energy, blood pressure, and stress responses. Congenital adrenal hyperplasia (CAH) is a group of inherited disorders where the adrenal glands lack an enzyme (most commonly 21-hydroxylase) needed to make cortisol. This leads to enlarged adrenal glands and abnormally high levels of 17-OHP.

What is it used for?

The 17-OHP test is used to:

  • Screen newborns for severe (classic) CAH.
  • Diagnose mild (nonclassic) CAH in children, teens, and adults.
  • Monitor the effectiveness of CAH treatment.
  • Rule out CAH in women experiencing symptoms like facial hair or irregular periods.

Why do I need a 17-OHP test?

Newborns: Routine screening is performed shortly after birth to detect severe CAH, which can be life-threatening if untreated. Symptoms include dehydration, vomiting, diarrhea, and failure to thrive.

Children, Teens, and Adults: Testing may be necessary if symptoms of mild CAH appear, such as:

  • Girls/Women: Excess facial/body hair, irregular periods, thinning hair, or infertility.
  • Boys/Men: Enlarged penis with small testicles, low sperm count, or infertility.
  • General: Early puberty, rapid growth followed by short stature, or severe acne.

What happens during the test?

  • Newborns: A professional cleans the baby's heel and uses a small needle to collect a few drops of blood.
  • Older children/Adults: A standard blood sample is drawn from a vein in the arm.

What do the results mean?

  • Normal levels: It is unlikely that you or your child has CAH caused by 21-hydroxylase deficiency.
  • High levels: Suggests the presence of CAH. Your provider may order further testing.
  • Decreasing levels: If you are already being treated for CAH, a decrease in 17-OHP levels indicates that the treatment is working.

If results are unclear, a provider may order an ACTH stimulation test, which measures how your adrenal glands respond to an injection of ACTH hormone.

Frequently Asked Questions

For adults and older children being tested for nonclassic CAH, the timing of the blood draw is critical because 17-OHP levels fluctuate throughout the day. The test is most accurate when performed in the morning, ideally between 8:00 AM and 10:00 AM, before any cortisol medication has been taken for that day. Drawing blood in the afternoon or evening can result in falsely low levels, potentially leading to a missed diagnosis of mild CAH. Can oral contraceptives or other medications interfere with 17-hydroxyprogesterone test results?::Yes, certain medications can alter 17-OHP levels. Oral contraceptives containing progestins can elevate 17-OHP levels, potentially causing a false positive or masking the true baseline. Additionally, if you are already taking glucocorticoids (like hydrocortisone or prednisone) for suspected CAH, these suppress adrenal activity and will lower 17-OHP levels. Your doctor may need to adjust the timing of the test relative to your medication schedule or interpret results in the context of your current treatment. What are the specific warning signs in a newborn that require immediate medical attention while waiting for 17-OHP screening results?::While waiting for newborn screening results, parents should watch for signs of a salt-wasting crisis, which is a life-threatening emergency associated with classic CAH. These signs include persistent vomiting, lethargy, poor feeding, dehydration, and rapid weight loss. If a newborn exhibits these symptoms, they should be taken to the emergency room immediately, as prompt treatment with fluids and steroids is required to prevent shock and organ failure. How is the 17-OHP test used to monitor treatment effectiveness in patients already diagnosed with CAH?::In diagnosed patients, the 17-OHP test serves as a biomarker for disease control. Doctors aim to keep 17-OHP levels within a specific target range, often slightly above the normal reference range, to ensure the adrenal glands are not being over-suppressed by medication. If levels are consistently too high, it indicates under-treatment and a risk of adrenal stress; if too low, it may indicate over-treatment, which can lead to growth suppression in children or metabolic issues in adults. Regular monitoring allows for precise dose adjustments of glucocorticoids.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab